SOURCE: Horizon Pharma plc

Horizon Pharma plc

September 22, 2014 16:05 ET

Horizon Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Conference

DUBLIN, IRELAND--(Marketwired - Sep 22, 2014) - Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, today announced that Robert F. Carey, executive vice president and chief business officer, will present at the 21st Annual NewsMakers in the Biotech Industry Conference on Friday, September 26, 2014 at 11:00 a.m. Eastern Time in New York, NY. Mr. Carey will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.

About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The company markets a portfolio of products in arthritis, inflammation and orphan diseases. The company's U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS®(ibuprofen/famotidine), RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.

Contact Information

  • Contact
    Elizabeth M. Higashi, CFA
    Vice President, Investor Relations
    Email Contact